Cargando…

No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls

BACKGROUND: Previous studies have indicated that peripheral circulating markers of inflammation are elevated in women with polycystic ovary syndrome (PCOS), but thus far no studies concerning markers of inflammation in adipose tissue have been published. The aim of the study was to investigate wheth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindholm, Åsa, Blomquist, Caroline, Bixo, Marie, Dahlbom, Ingrid, Hansson, Tony, Sundström Poromaa, Inger, Burén, Jonas
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2011
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096560/ https://www.ncbi.nlm.nih.gov/pubmed/21478181 http://dx.doi.org/10.1093/humrep/der096

Ejemplares similares

Low- and Fully N-Glycosylated Gonadotropins Circulating in Women With Polycystic Ovary Syndrome
por: Wide, Leif, et al.
Publicado: (2021)

Serum retinol-binding protein 4 levels in polycystic ovary syndrome
por: Lingaiah, Shilpa, et al.
Publicado: (2019)

Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital(®) Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study
por: Fianu Jonasson, Aino, et al.
Publicado: (2020)

Polycystic ovary syndrome and extremely preterm birth: A nationwide register-based study
por: Valgeirsdottir, Heiddis, et al.
Publicado: (2021)

Down-regulation of progesterone receptor membrane component 1 (PGRMC1) in peripheral nucleated blood cells associated with premature ovarian failure (POF) and polycystic ovary syndrome (PCOS)
por: Schuster, Jens, et al.
Publicado: (2010)

Negative Association Between Allopregnanolone and Cerebral Serotonin Transporter Binding in Healthy Women of Fertile Age
por: Sundström Poromaa, Inger, et al.
Publicado: (2019)

Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome
por: Panico, Annalisa, et al.
Publicado: (2017)

Impact of maternal central adiposity on infant anthropometry and perinatal morbidity: A systematic review
por: Lindberger, Emelie, et al.
Publicado: (2020)

Prevalence and sensitization of atopic allergy and coeliac disease in the Northern Sweden Population Health Study
por: Enroth, Stefan, et al.
Publicado: (2013)

Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids
por: Stiernman, Louise, et al.
Publicado: (2023)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood
por: Tata, Brooke, et al.
Publicado: (2018)

Differential grey matter structure in women with premenstrual dysphoric disorder: evidence from brain morphometry and data-driven classification
por: Dubol, Manon, et al.
Publicado: (2022)

Ovulatory status of overweight women without Polycystic Ovary Syndrome
por: Sasaki, Reinaldo S. A., et al.
Publicado: (2019)

Early initiation of anti-androgen treatment is associated with increased probability of spontaneous conception leading to childbirth in women with polycystic ovary syndrome: a population-based multiregistry cohort study in Sweden
por: Elenis, E, et al.
Publicado: (2021)

Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment
por: Edvinsson, Åsa, et al.
Publicado: (2020)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder
por: Wikman, Anna, et al.
Publicado: (2022)

Insulin resistance and adverse metabolic profile in overweight/obese and normal weight of young women with polycystic ovary syndrome
por: Gholinezhad, Maryam, et al.
Publicado: (2018)

Predictors of Lifestyle Intervention Attrition or Weight Loss Success in Women with Polycystic Ovary Syndrome Who Are Overweight or Obese
por: Moran, Lisa J., et al.
Publicado: (2019)

Effect of obesity on human reproduction
por: Poromaa, Inger Sundström
Publicado: (2015)

Effects of a ketogenic diet in overweight women with polycystic ovary syndrome
por: Paoli, Antonio, et al.
Publicado: (2020)

Gene expression in subcutaneous adipose tissue differs in women with polycystic ovary syndrome and controls matched pair-wise for age, body weight, and body mass index
por: Mannerås-Holm, Louise, et al.
Publicado: (2014)

White matter microstructure and volume correlates of premenstrual dysphoric disorder
por: Gu, Xuan, et al.
Publicado: (2022)

Anti-Inflammatory Dietary Combo in Overweight and Obese Women with Polycystic Ovary Syndrome
por: Salama, Amany Alsayed, et al.
Publicado: (2015)

Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome
por: Rissanen, Antti‐Pekka E., et al.
Publicado: (2016)

Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome
por: Yu, Jin, et al.
Publicado: (2023)

Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum
por: Bränn, Emma, et al.
Publicado: (2019)

TMT Based Proteomic Analysis of Human Follicular Fluid From Overweight/Obese and Normal-Weight Patients With Polycystic Ovary Syndrome
por: Zhang, Xinyi, et al.
Publicado: (2019)

Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome
por: Kokosar, Milana, et al.
Publicado: (2016)

Ultrasound estimated subcutaneous and visceral adipose tissue thicknesses and risk of pre-eclampsia
por: Pétursdóttir Maack, Heidrun, et al.
Publicado: (2021)

Menstrual cycle influence on cognitive function and emotion processing—from a reproductive perspective
por: Sundström Poromaa, Inger, et al.
Publicado: (2014)

New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder
por: Sundström-Poromaa, Inger, et al.
Publicado: (2023)

Changes in HbA(1c) and circulating and adipose tissue androgen levels in overweight‐obese women with polycystic ovary syndrome in response to electroacupuncture
por: Stener‐Victorin, E., et al.
Publicado: (2016)

The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2019)

The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome
por: Wang, Haiyan, et al.
Publicado: (2023)

Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe
por: Piltonen, Terhi T., et al.
Publicado: (2019)

Sexual function and combined oral contraceptives: a randomised, placebo-controlled trial
por: Lundin, Cecilia, et al.
Publicado: (2018)

Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome
por: Abazar, Elaheh, et al.
Publicado: (2015)

“The whole package deal”: experiences of overweight/obese women living with polycystic ovary syndrome
por: Ee, Carolyn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_en99908n6h208sg47pshoqp7bg